Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Treasury Shares (2016 - 2025)

Lisata Therapeutics filings provide 11 years of Treasury Shares readings, the most recent being $708000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $708000.0, compared with a TTM value of $708000.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of $708000.0, changed 0.0% over the prior year.
  • Treasury Shares hit $265036.0 in Q4 2025 for Lisata Therapeutics, roughly flat from $265036.0 in the prior quarter.
  • The five-year high for Treasury Shares was $265036.0 in Q3 2025, with the low at $738.0 in Q1 2023.
  • Median Treasury Shares over the past 3 years was $43041.5 (2023), compared with a mean of $97447.8.
  • The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • Year by year, Treasury Shares stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $708000.0, $708000.0, and $708000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.